Targeted Delivery of Anti-Inflammatory Agents to Tumors
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1825-1843
Author(s):
Maria Coimbra, Sylvia A. Kuijpers, Sebastiaan P. van Seters, Gert Storm and Raymond M. Schiffelers
Towards Understanding the Role of Cancer-Associated Inflammation in Chemoresistance
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1844-1853
Author(s):
Karin E. de Visser and Jos Jonkers
III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1854-1867
Author(s):
Mitsuko Furuya, Yoshikazu Yonemitsu and Ichiro Aoki
Mast Cells as Target in Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1868-1878
Author(s):
Tom Groot Kormelink, Abulikemu Abudukelimu and Frank A. Redegeld
Regulatory T Cells: Major Players in the Tumor Microenvironment
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1879-1892
Author(s):
Marc Beyer and Joachim L. Schultze
Involvement of Nucleotide Excision and Mismatch Repair Mechanisms in Double Strand Break Repair
Journal:
Current Genomics
Volume:
10
Page:
250-258
Author(s):
Ye Zhang, Larry H. Rohde and Honglu Wu
HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
451-468
Author(s):
Jeremy Chien, Mara Campioni, Viji Shridhar and Alfonso Baldi
Biomarkers for Risk Assessment and Prevention of Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
482-499
Author(s):
Massimiliano Cazzaniga, Andrea Decensi, Bernardo Bonanni, Alberto Luini and Oreste Gentilini
Exposure of B Cell Chronic Lymphocytic Leukemia (B-CLL) Cells to Nutlin-3 Induces a Characteristic Gene Expression Profile, which Correlates with Nutlin-3-Mediated Cytotoxicity (Supplementry Table)
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
510-518
Author(s):
G. Zauli, M. G. di Iasio, P. Secchiero, M. Dal Bo, D. Marconi, R. Bomben, G. Del Poeta and V. Gattei
The Biological Functions of NF-κB1 (p ) and its Potential as an Anti-Cancer Target
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
566-571
Author(s):
Yonghui Yu, Yu Wan and Chuanshu Huang